Lake Street lowered the firm’s price target on Elutia (ELUT) to $8 from $10 and keeps a Buy rating on the shares. The firm thinks EluPro is “off to a remarkable start” and continues to believe a strategic exit materially above the company’s current value is “the most likely outcome,” though it reduced its price target on less value ascribed to SimpliDerm.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELUT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue